Business Context and Reporting Period
Company: CalciMedica, Inc. (CALC)
Filing Type: Form 8-K (Current Report)
Date of Report: May 15, 2023
Reporting Period: Fiscal quarter ended March 31, 2023
Trading Status: Common stock began trading on the OTC QB on April 26, 2023, under the symbol "CALC".
Key Financial Metrics
The provided filing text serves as a cover document referencing a press release (Exhibit 99.1) for the quarter ended March 31, 2023. The text does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These details are contained within the referenced press release, which is not included in the input text.
Material Changes
No specific material changes in financial performance or operations are detailed in the text of this 8-K filing. The filing solely announces the issuance of the Q1 2023 financial results press release.
Guidance, Outlook, and Risks
Management Commentary: The filing notes the issuance of a press release regarding Q1 2023 results but does not include the content of that commentary.
Legal Disclaimer: The information in Item 2.02 and Exhibit 99.1 is not deemed "filed" for purposes of Section 18 of the Exchange Act and shall not be incorporated by reference into other filings unless expressly stated.
Investor Verification Checklist
- Review the attached press release (Exhibit 99.1) for specific Q1 2023 revenue, net loss, and cash burn figures.
- Verify the company's current liquidity position and runway based on the Q1 2023 results.
- Confirm the trading status and volume on the OTC QB exchange following the April 26, 2023 listing.
- Check for any updates on clinical trial progress or regulatory milestones mentioned in the full press release.